Nurse-led healthcare intervention for women's health in Hong Kong

Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong

Not applicable Interventional The University of Hong Kong · NCT06628388

This study tests a new healthcare program led by nurses to see if it helps women aged 45 to 64 in Hong Kong manage their health better, especially for issues like hot flashes, anxiety, and osteoporosis.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment1728 (estimated)
Ages45 Years to 64 Years
SexFemale
SponsorThe University of Hong Kong Academic / other
Locations3 sites (Hong Kong and 2 other locations)
Trial IDNCT06628388 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to evaluate the effectiveness of a nurse-led primary healthcare intervention model designed for women aged 45 to 64 in Hong Kong. The intervention focuses on improving health management related to conditions such as vasomotor symptoms, urinary incontinence, anxiety, depression, and osteoporosis. Participants will be randomly assigned to either the intervention group or a control group, with assessments made on medical resource use, health confidence, self-management, quality of life, and health condition risk levels over time. The study also seeks to develop an evidence-based model for women's health management in primary care settings.

Who should consider this trial

Good fit: Ideal candidates are Hong Kong female residents aged 45 to 64 who can read and communicate in Chinese.

Not a fit: Patients with terminal illnesses, severe psychiatric disorders, or significant cognitive impairments may not benefit from this intervention.

Why it matters

Potential benefit: If successful, this intervention could enhance women's health management and improve quality of life for middle-aged women in Hong Kong.

How similar studies have performed: While nurse-led interventions have shown promise in various healthcare settings, this specific model targeting women's health in Hong Kong is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Hong Kong female residents aged 45 to 64 years old; and
2. Able to read and communicate in Chinese (either Cantonese or Mandarin).

Exclusion Criteria:

1. Have a terminal illness (e.g., advanced cancer, dementia, pulmonary, neurological, motor-neuron, and advanced cardiovascular disease), or with a life expectancy of less than six months;
2. Diagnosed with psychiatric or psychological disorders (e.g., panic disorder, psychosis);
3. Currently taking medication(s) or receiving treatment(s) for psychiatric and psychological disorders;
4. Pregnant or in lactation period, or have plans for pregnancy within 1 year; or
5. Have moderate or severe cognitive impairment.

Where this trial is running

Hong Kong and 2 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Vasomotor SymptomsUrinary IncontinenceAnxietyDepression - Major Depressive DisorderOsteoporosisBreast CancerHypertensionCervical Cancers
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.